UnitedHealth (UNH) reported Q2 FY2024 earnings of $6.80 per share (versus $6.14 per share in Q2 FY2023), beating analysts’ consensus estimate of $6.66 per share.
The company’s quarterly revenues amounted to $98.855 bln (+6.4% y/y), slightly beating analysts’ consensus estimate of $98.732 bln.
The company also reaffirmed guidance for FY2024, seeing EPS of $27.50-28.00 versus analysts’ consensus estimate of $27.70.
UNH fell to $501.50 (-2.69%) in pre-market trading.